BioNexus Gene Lab
BGLC
#9821
Rank
C$8.77 M
Marketcap
$0.49
Share price
-2.44%
Change (1 day)
-11.34%
Change (1 year)

Operating Margin for BioNexus Gene Lab (BGLC)

Operating Margin as of November 2024 (TTM): -22.96%

According to BioNexus Gene Lab's latest financial reports and stock price the company's current Operating Margin is -22.96%. At the end of 2022 the company had an Operating Margin of -2.66%.

Operating Margin history for BioNexus Gene Lab from 2019 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-2.66%-133.72%
20217.90%-29.35%
202011.18%-105.15%
2019-217.17%-869.78%
201828.21%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.